Gastro Education 2018
Journal of Clinical Gastroenterology and Hepatology
ISSN: 2575-7733
Page 33
September 06-07, 2018
London, UK
14
th
International Conference on
Gastro Education
I
nflammatory bowel diseases (IBD); Crohn’s disease and
ulcerative colitis (UC), are idiopathic, intestinal and systemic
inflammatory disorders which are immunologically mediated
with activation of plasma proteolytic cascades. Activation of
coagulation in IBD is related to activity and colonic extension of
the disease, but may be still persistent in quiescent stage. Factor
XIII seems to be as much coagulation factor as connective tissue
factor which may contribute to intestinal healing. Fibrinolytic
capacity is reduced in general circulation of IBDpatients, but a role
of recently recognized thrombin – activatable fibrinolytic inhibitor
is unclear. Platelets activation is a feature of IBD and contribute to
pathogenic inflammatory sequel. There are evidences that in turn
coagulation activation may mediate and amplify inflammatory
cascades in IBD especially via activating PARs related pathways.
The etiology of thromboembolism in IBD is likely multifactorial
but largely attributable to coagulation activation, and platelet
aggregation during systemic inflammation. Thromboembolic (TE)
complications in both Crohn’s disease and UC appear to have at
least 3-4 fold increased risk of developing compared to control
patients. Currently no single TE laboratory marker has predictive
value, but recently developed endogenous thrombin potential test
may predictive potential value in IBD. At present no interaction
between IBD and inherited factors of thrombophilia was found.
An efficacy of heparin treatment in UC is still controversial and
not established, although heparin is safe in UC flare. Prophylactic
anticoagulation against TE is currently defined, moderate and
high-risk patients should be considered for using moderate dose
of heparin.
Biography
Dr. Antoni worked in Thrombosis Research Center, Temple University Med-
ical School, Philadelphia, USA, having faculty position, investigated a role
of plasma and intestinal tissue kallikrein kinin system in experimental IBD,
in collaboration with Prof. Dr. RB Sartor, NC, and Chapel Hill, US. Currently
working as Professor, Silesian Medical University doing research, medical
practice, and teaching students. He has supervised two large research proj-
ects founded by Polish Ministry of Sciences related to pathogenesis and
treatment of human IBD. He also continued IBD coagulation study to eval-
uate link of coagulation-inflammation in joints and gut diseases, and anti
- platelets agents (Clopidogrel) interactions with proton pump inhibitors. My
recent projects were also related to the tissue kallikrein kinin system, and ki-
nin receptors in colorectal polyps, and colorectal cancer as well as a signifi-
cance of angiogenesis related to kinins and grow factors in ulcerative colitis.
astadnic@wp.plInvolvement of coagulation and hemostasis in inflammatory
bowel diseases
Antoni Stadnicki
Medical University of Silesia, Poland
Antoni Stadnicki, J Clin Gastroenterol Hepatol 2018, Volume 2
DOI: 10.21767/2575-7733-C2-005




